MAOB and depressive symptom measurement: Depression in PD may be partially related to dopamine deficiency in limbic system pathways [25], and enhancement of dopaminergic neurotransmission via a selective MAO-B inhibitor could therefore interfere in affective pathways related to onset of depression in PD.